Close Menu

NEW YORK — MBio Diagnostics said today that it has been awarded a roughly $1 million grant from the National Institutes of Health grant to develop a point-of-care assay for sepsis.

The company also said it has received a contract from the Henry M. Jackson Foundation for a separate sepsis test, but the size of the contract was not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.